Mark Peyrot

Summary

Publications

  1. pmc Perceived medication benefits and their association with interest in using inhaled insulin in type 2 diabetes: a model of patients' cognitive framework
    Mark Peyrot
    Department of Sociology, Loyola University, MD, USA
    Patient Prefer Adherence 5:255-65. 2011
  2. pmc Development and validation of the self-management profile for type 2 diabetes (SMP-T2D)
    Mark Peyrot
    Department of Sociology, Loyola University Maryland, Baltimore, MD, USA
    Health Qual Life Outcomes 10:125. 2012
  3. doi request reprint Validation of a tool to assess medication treatment satisfaction in patients with Type 2 diabetes: the Diabetes Medication System Rating Questionnaire (DMSRQ)
    M Peyrot
    Department of Sociology, Loyola University Maryland, Baltimore, MD, USA
    Diabet Med 29:1060-6. 2012
  4. doi request reprint Associations between improved glucose control and patient-reported outcomes after initiation of insulin pump therapy in patients with type 2 diabetes mellitus
    Mark Peyrot
    Loyola University Maryland, Baltimore, Maryland, USA
    Diabetes Technol Ther 13:471-6. 2011
  5. doi request reprint Barriers to insulin injection therapy: patient and health care provider perspectives
    Richard R Rubin
    Department of Medicine, Hopkins University, Baltimore, Maryland, USA
    Diabetes Educ 35:1014-22. 2009
  6. doi request reprint Effect of technosphere inhaled insulin on quality of life and treatment satisfaction
    Mark Peyrot
    Department of Sociology, Loyola University Maryland, Baltimore, Maryland, USA
    Diabetes Technol Ther 12:49-55. 2010
  7. pmc Correlates of insulin injection omission
    Mark Peyrot
    Department of Sociology, Loyola University Maryland, Baltimore, Maryland, USA
    Diabetes Care 33:240-5. 2010
  8. pmc Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump
    Richard R Rubin
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Diabetes Sci Technol 3:1402-10. 2009
  9. doi request reprint Patient-reported outcomes from a 16-week open-label, multicenter study of insulin pump therapy in patients with type 2 diabetes mellitus
    Richard R Rubin
    Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Diabetes Technol Ther 12:901-6. 2010
  10. doi request reprint Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to addition of mealtime pramlintide or rapid-acting insulin analogs
    Mark Peyrot
    Loyola University Maryland, Baltimore, MD 21210, USA
    Curr Med Res Opin 26:1047-54. 2010

Detail Information

Publications41

  1. pmc Perceived medication benefits and their association with interest in using inhaled insulin in type 2 diabetes: a model of patients' cognitive framework
    Mark Peyrot
    Department of Sociology, Loyola University, MD, USA
    Patient Prefer Adherence 5:255-65. 2011
    ..To examine predictors of patient perceived relevance of different diabetes medication benefits, and to determine how medication benefit ratings of an inhaled insulin were associated with evaluation of, and interest in that inhaled insulin...
  2. pmc Development and validation of the self-management profile for type 2 diabetes (SMP-T2D)
    Mark Peyrot
    Department of Sociology, Loyola University Maryland, Baltimore, MD, USA
    Health Qual Life Outcomes 10:125. 2012
    ..This study evaluated the measurement properties of a newly developed instrument - the Self-Management Profile for Type 2 Diabetes (SMP-T2D)...
  3. doi request reprint Validation of a tool to assess medication treatment satisfaction in patients with Type 2 diabetes: the Diabetes Medication System Rating Questionnaire (DMSRQ)
    M Peyrot
    Department of Sociology, Loyola University Maryland, Baltimore, MD, USA
    Diabet Med 29:1060-6. 2012
    ....
  4. doi request reprint Associations between improved glucose control and patient-reported outcomes after initiation of insulin pump therapy in patients with type 2 diabetes mellitus
    Mark Peyrot
    Loyola University Maryland, Baltimore, Maryland, USA
    Diabetes Technol Ther 13:471-6. 2011
    ....
  5. doi request reprint Barriers to insulin injection therapy: patient and health care provider perspectives
    Richard R Rubin
    Department of Medicine, Hopkins University, Baltimore, Maryland, USA
    Diabetes Educ 35:1014-22. 2009
    ..To compare patients' perceptions of injection-related problems with clinicians' estimates of those problems...
  6. doi request reprint Effect of technosphere inhaled insulin on quality of life and treatment satisfaction
    Mark Peyrot
    Department of Sociology, Loyola University Maryland, Baltimore, Maryland, USA
    Diabetes Technol Ther 12:49-55. 2010
    ..This randomized controlled trial assessed the impact of Technosphere insulin (MannKind Corp., Valencia, CA) delivered via the MedTone inhaler (MannKind Corp.) on quality of life and treatment satisfaction in adults with type 2 diabetes...
  7. pmc Correlates of insulin injection omission
    Mark Peyrot
    Department of Sociology, Loyola University Maryland, Baltimore, Maryland, USA
    Diabetes Care 33:240-5. 2010
    ..The purpose of this study was to assess factors associated with patient frequency of intentionally skipping insulin injections...
  8. pmc Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump
    Richard R Rubin
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Diabetes Sci Technol 3:1402-10. 2009
    ....
  9. doi request reprint Patient-reported outcomes from a 16-week open-label, multicenter study of insulin pump therapy in patients with type 2 diabetes mellitus
    Richard R Rubin
    Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Diabetes Technol Ther 12:901-6. 2010
    ..This study assessed patient-reported outcomes (PRO) for patients with type 2 diabetes treated by insulin pump therapy...
  10. doi request reprint Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to addition of mealtime pramlintide or rapid-acting insulin analogs
    Mark Peyrot
    Loyola University Maryland, Baltimore, MD 21210, USA
    Curr Med Res Opin 26:1047-54. 2010
    ..To determine whether treatment satisfaction and quality of life were affected by adding mealtime pramlintide or rapid-acting insulin analogs (RAIAs) to basal insulin therapy for patients with inadequately controlled type 2 diabetes...
  11. doi request reprint Diabetes distress and its association with clinical outcomes in patients with type 2 diabetes treated with pramlintide as an adjunct to insulin therapy
    Mark Peyrot
    Department of Sociology, Loyola College in Maryland, Baltimore, MD 21210, USA
    Diabetes Technol Ther 10:461-6. 2008
    ..This study was designed to assess diabetes-related distress and its association with clinical outcomes in patients with type 2 diabetes using basal insulin who were treated with pramlintide...
  12. ncbi request reprint Physician and nurse use of psychosocial strategies in diabetes care: results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study
    Mark Peyrot
    Department of Sociology, Loyola College, 4501 North Charles St, Baltimore, MD 21210 2699, USA
    Diabetes Care 29:1256-62. 2006
    ..To determine the use of psychosocial strategies by health care providers in treating patients with diabetes and the factors associated with use of these strategies...
  13. pmc Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study
    Richard R Rubin
    Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Diabetes Care 33:2549-51. 2010
    ..To assess the association between antidepressant medicine use and risk of developing diabetes during the Diabetes Prevention Program (DPP) and Diabetes Prevention Program Outcomes Study (DPPOS)...
  14. doi request reprint Psychometric properties of an instrument for assessing treatment satisfaction associated with pramlintide use
    Richard R Rubin
    John Hopkins University School of Medicine, Baltimore, Maryland, USA
    Diabetes Educ 35:136-46. 2009
    ..Thus, it is important to understand how patients experience a new treatment...
  15. pmc Psychometric properties of an instrument for assessing the experience of patients treated with inhaled insulin: the inhaled insulin treatment questionnaire (IITQ)
    Richard R Rubin
    Department of Medicine, The Johns Hopkins University School of Medicine, 946 East Piney Hill Road, Monkton, Baltimore, Maryland, MD 21111, USA
    Health Qual Life Outcomes 8:32. 2010
    ....
  16. doi request reprint Access to diabetes self-management education: results of national surveys of patients, educators, and physicians
    Mark Peyrot
    Department of Sociology, Loyola College, 4501 North Charles Street, Baltimore, MD 21210 2699, USA
    Diabetes Educ 35:246-8, 252-6, 258-63. 2009
    ....
  17. ncbi request reprint Assessing treatment satisfaction in patients treated with pramlintide as an adjunct to insulin therapy
    Richard R Rubin
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Curr Med Res Opin 23:1919-29. 2007
    ..Assessment included the association between treatment satisfaction and clinical outcomes (changes in post-prandial glucose [PPG], glycosylated hemoglobin [HbA(1c)], weight, and insulin requirements)...
  18. ncbi request reprint Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies
    Richard R Rubin
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Diabetes Care 27:2495-7. 2004
  19. pmc Effect of problem-solving-based diabetes self-management training on diabetes control in a low income patient sample
    Felicia Hill-Briggs
    Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA
    J Gen Intern Med 26:972-8. 2011
    ..Diabetes self-management support interventions are needed that are effective in engaging lower income patients, addressing competing life priorities and barriers to self-care, and facilitating behavior change...
  20. doi request reprint Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system
    Mark Peyrot
    Department of Sociology, Loyola College in Maryland, Baltimore, 21210 2699, USA
    Diabetes Technol Ther 11:57-62. 2009
    ....
  21. ncbi request reprint Patient-reported outcomes and diabetes technology: a systematic review of the literature
    Richard R Rubin
    Department of Medicine, Johns Hopkins University School of Medicine Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Pediatr Endocrinol Rev 7:405-12. 2010
    ..Advanced diabetes technology should have benefits not only in terms of clinical outcomes, but also in terms of patient-reported outcomes...
  22. ncbi request reprint Health care and patient-reported outcomes: results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study
    Richard R Rubin
    Department of Medicine, The Johns Hopkins University, Baltimore, MD, USA
    Diabetes Care 29:1249-55. 2006
    ..The purpose of this study was to assess the relationship of patients' self-reported well-being, self-management, and diabetes control with factors related to the patient's health care...
  23. doi request reprint Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial
    Richard R Rubin
    Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Diabetes Technol Ther 14:143-51. 2012
    ..Patient acceptance of new therapies is essential to their adoption and effective use...
  24. doi request reprint Patient-reported outcomes in adults with type 2 diabetes using mealtime inhaled technosphere insulin and basal insulin versus premixed insulin
    Mark Peyrot
    Department of Sociology, Loyola University Maryland, 4501 North Charles Street, Baltimore, MD 21210, USA
    Diabetes Technol Ther 13:1201-6. 2011
    ..Valencia, CA) and basal insulin (insulin glargine) or premixed aspart insulin 70/30...
  25. doi request reprint Epidemiology and correlates of weight worry in the multinational Diabetes Attitudes, Wishes and Needs study
    Mark Peyrot
    Department of Sociology, Loyola College, Baltimore, MD 21210 2699, USA
    Curr Med Res Opin 25:1985-93. 2009
    ..This study examined the epidemiology of worry about weight among adults with diabetes and whether this weight worry was associated with worse quality of life and diabetes self-management...
  26. ncbi request reprint Validity and reliability of an instrument for assessing health-related quality of life and treatment preferences: the Insulin Delivery System Rating Questionnaire
    Mark Peyrot
    Department of Sociology and Center for Social and Community Research, Loyola College, Baltimore, Maryland 21210 2699, USA
    Diabetes Care 28:53-8. 2005
    ..To provide a preliminary assessment of the validity and reliability of a new measure of health-related quality of life (HRQOL) and treatment preference for insulin delivery systems...
  27. pmc How does treatment satisfaction work?: Modeling determinants of treatment satisfaction and preference
    Mark Peyrot
    Department of Sociology, Loyola College, Baltimore, Maryland
    Diabetes Care 32:1411-7. 2009
    ..Perceived treatment consequences mediated the effect of objective clinical benefits on satisfaction with and preference for the study medication...
  28. doi request reprint Addressing barriers to initiation of insulin in patients with type 2 diabetes
    Mark Peyrot
    Loyola University Maryland, Baltimore, Maryland, USA
    Prim Care Diabetes 4:S11-8. 2010
    ....
  29. pmc Four-year analysis of cardiovascular disease risk factors, depression symptoms, and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes
    Richard R Rubin
    Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Diabetes Care 36:1088-94. 2013
    ..To study the association of depressive symptoms or antidepressant medicine (ADM) use with subsequent cardiovascular disease (CVD) risk factor status in the Look AHEAD (Action for Health in Diabetes) trial of weight loss in type 2 diabetes...
  30. ncbi request reprint Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study
    Mark Peyrot
    Department of Sociology, Loyola College, Baltimore, MD 21210 2699, USA
    Diabetes Care 28:2673-9. 2005
    ..To examine the correlates of patient and provider attitudes toward insulin therapy...
  31. ncbi request reprint Factors affecting use of insulin pens by patients with type 2 diabetes
    Richard R Rubin
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Diabetes Care 31:430-2. 2008
    ..To assess factors that might affect patient use of insulin pens...
  32. pmc Development and pilot evaluation of literacy-adapted diabetes and CVD education in urban, diabetic African Americans
    Felicia Hill-Briggs
    Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA
    J Gen Intern Med 23:1491-4. 2008
    ..Despite prevalent low literacy nationally, empirical research on the development and testing of literacy-adapted patient education remains limited...
  33. doi request reprint Factors associated with persistence and resumption of insulin pen use for patients with type 2 diabetes
    Mark Peyrot
    Department of Sociology, Loyola University Maryland, Baltimore, Maryland 21210 2699, USA
    Diabetes Technol Ther 13:43-8. 2011
    ..this study assessed patient-related factors associated with persistence and resumption of using pens as insulin delivery devices...
  34. doi request reprint Access to diabetes self-management education
    Mark Peyrot
    Department of Sociology, Loyola College and the Department of Medicine, John Hopkins University, Baltimore, MD, USA
    Diabetes Educ 34:90-7. 2008
    ....
  35. doi request reprint Physician perception and recommendation of insulin pens for patients with type 2 diabetes mellitus
    Mark Peyrot
    Department of Sociology, Loyola College, Baltimore, MD 21210 2699, USA
    Curr Med Res Opin 24:2413-22. 2008
    ..To determine the way in which physicians perceive insulin pens and the factors that affect their recommendations and their patients' pen initiation/use...
  36. ncbi request reprint Evolution of the American Association of Diabetes Educators' diabetes education outcomes project
    Malinda Peeples
    American Association of Diabetes Educators, 100 West Monroe Street, Chicago, IL 60603, USA
    Diabetes Educ 33:794-817. 2007
    ....
  37. pmc Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program
    Richard R Rubin
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Diabetes Care 31:420-6. 2008
    ..To assess the association between elevated depression symptoms or antidepressant medicine use on entry to the Diabetes Prevention Program (DPP) and during the study and the risk of developing diabetes during the study...
  38. doi request reprint Diabetes Attitudes Wishes and Needs 2 (DAWN2): a multinational, multi-stakeholder study of psychosocial issues in diabetes and person-centred diabetes care
    Mark Peyrot
    Department of Sociology, Loyola University Maryland, 4501 North Charles Street, Baltimore, MD 21210, USA
    Diabetes Res Clin Pract 99:174-84. 2013
    ....
  39. doi request reprint An observational study to validate the Satisfaction Measure of the Injection of Growth Hormone Therapy (SMIGHTy) questionnaire
    Richard R Rubin
    Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Curr Med Res Opin 27:2009-17. 2011
    ....
  40. ncbi request reprint Development of the American Association of Diabetes Educators' Diabetes Self-management Assessment Report Tool
    Mark Peyrot
    Department of Sociology, Loyola College, 4501 North Charles Street, Baltimore, MD 21210, USA
    Diabetes Educ 33:818-26. 2007
    ..The D-SMART was designed through expert panel consensus based on a hybrid conceptual framework and is intended to serve multiple functions at the level of the patient, the program, and the field...
  41. ncbi request reprint Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes
    Tiffany L Gary
    Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland, USA
    Diabetes Educ 29:488-501. 2003
    ..This meta-analysis was conducted to assess the effect of educational and behavioral interventions on body weight and glycemic control in type 2 diabetes...